Mackenzie Financial Corp Merck & Co., Inc. Transaction History

Mackenzie Financial Corp

$63.2 Billion
Q2 2024

A detailed history of Mackenzie Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 2,339,106 shares of MRK stock, worth $266 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

2,339,106

Previous 2,189,127 6.85%

Holding current value

$266 Million

Previous $289 Million 0.25%

% of portfolio

0.46%

Previous 0.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $18.6 Million - $19.9 Million	149,979 Added 6.85%	2,339,106 $290 Million
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $22 Million - $25.6 Million	193,843 Added 9.72%	2,189,127 $289 Million
Q4 2023 Jan 30, 2024	BUY	$100.18 - $109.02 $30 Million - $32.6 Million	299,077 Added 17.63%	1,995,284 $218 Million
Q3 2023 Oct 25, 2023	SELL	$102.95 - $114.33 $6.79 Million - $7.54 Million	-65,907 Reduced 3.74%	1,696,207 $175 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $84.3 Million - $91.8 Million	-775,785 Reduced 30.57%	1,762,114 $203 Million
Q1 2023 Apr 24, 2023	BUY	$102.94 - $114.86 $4.84 Million - $5.4 Million	47,005 Added 1.89%	2,537,899 $270 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $1.1 Million - $1.4 Million	12,531 Added 0.51%	2,490,894 $276 Million
Q3 2022 Oct 07, 2022	BUY	$84.53 - $94.96 $8.45 Million - $9.49 Million	99,935 Added 4.2%	2,478,363 $213 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $19.2 Million - $21.8 Million	230,261 Added 10.72%	2,378,428 $217 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $180,834 - $202,704	2,460 Added 0.11%	2,148,167 $176 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $11.6 Million - $14.5 Million	160,345 Added 8.08%	2,145,707 $164 Million
Q3 2021 Nov 08, 2021	BUY	$71.68 - $78.83 $5.21 Million - $5.73 Million	72,702 Added 3.8%	1,985,362 $149 Million
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $2.88 Million - $3.19 Million	-40,979 Reduced 2.1%	1,912,660 $149 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $14 Million - $16.5 Million	-203,456 Reduced 9.43%	1,953,639 $151 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $10.7 Million - $11.9 Million	-149,471 Reduced 6.48%	2,157,095 $176 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $33.5 Million - $37.9 Million	457,228 Added 24.72%	2,306,566 $191 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $574,275 - $653,460	-8,155 Reduced 0.44%	1,849,338 $136 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $34.1 Million - $47.3 Million	538,634 Added 40.84%	1,857,493 $136 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $9.61 Million - $10.8 Million	123,918 Added 10.37%	1,318,859 $120 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $802,187 - $874,413	10,544 Added 0.89%	1,194,941 $101 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $49.2 Million - $57.5 Million	705,176 Added 147.15%	1,184,397 $99.3 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $39.5 Million - $45 Million	-567,481 Reduced 54.22%	479,221 $39.9 Million
Q4 2018 Feb 06, 2019	SELL	$65.24 - $75.71 $10.9 Million - $12.7 Million	-167,694 Reduced 13.81%	1,046,702 $80 Million
Q3 2018 Nov 15, 2018	SELL	$57.69 - $67.84 $38.8 Million - $45.6 Million	-672,127 Reduced 35.63%	1,214,396 $86.1 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $185 Million - $218 Million	-3,643,055 Reduced 65.88%	1,886,523 $115 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $21 Million - $24.4 Million	-411,576 Reduced 6.93%	5,529,578 $301 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $306 Million - $365 Million	5,923,357 Added 33282.9%	5,941,154 $334 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $37,020 - $39,835	631 Added 3.68%	17,797 $1.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	17,166	17,166 $1.1 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Merck & Co., Inc. Transaction History